177 related articles for article (PubMed ID: 22213322)
1. The difference between 14-epi-previtamin D3 and 14-epi-19-norprevitamin D3: their synthesis and binding affinity for human VDR.
Sawada D; Katayama T; Tsukuda Y; Saito N; Saito H; Kakuda S; Takimoto-Kamimura M; Takenouchi K; Kittaka A
Anticancer Res; 2012 Jan; 32(1):319-26. PubMed ID: 22213322
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 2alpha-substituted-14-epi-previtamin D3 and its genomic activity.
Sawada D; Katayama T; Tsukuda Y; Saito N; Takano M; Saito H; Takagi K; Ochiai E; Ishizuka S; Takenouchi K; Kittaka A
Bioorg Med Chem Lett; 2009 Sep; 19(18):5397-400. PubMed ID: 19692243
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 2beta-substituted-14-epi-previtamin D3 and testing of its genomic activity.
Sawada D; Tsukuda Y; Saito H; Takagi K; Ochiai E; Ishizuka S; Takenouchi K; Kittaka A
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):20-4. PubMed ID: 20214990
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a 3-position diastereomer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71).
Hatakeyama S; Nagashima S; Imai N; Takahashi K; Ishihara J; Sugita A; Nihei T; Saito H; Takahashi F; Kubodera N
Bioorg Med Chem; 2006 Dec; 14(23):8050-6. PubMed ID: 16908172
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 14-epi-2α-hydroxypropoxy-1α,25-dihydroxy-19-nortachysterol and its hVDR binding.
Sawada D; Tsukuda Y; Saito H; Takagi K; Kakuda S; Takimoto-Kamimura M; Ochiai E; Takenouchi K; Kittaka A
J Steroid Biochem Mol Biol; 2013 Jul; 136():27-9. PubMed ID: 23246987
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of 16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs having side chains of different sizes.
Takaku H; Miyamoto Y; Asami S; Shimazaki M; Yamada S; Yamamoto K; Udagawa N; DeLuca HF; Shimizu M
Bioorg Med Chem; 2008 Feb; 16(4):1796-815. PubMed ID: 18032055
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 4-substituted vitamin d and 14-epi-previtamin d analogs.
Sawada D; Tsukuda Y; Saito H; Takagi K; Horie K; Ochiai E; Takenouchi K; Kittaka A
Chem Pharm Bull (Tokyo); 2009 Dec; 57(12):1431-3. PubMed ID: 19952459
[TBL] [Abstract][Full Text] [Related]
8. Development of 14-epi-19-nortachysterol and its unprecedented binding configuration for the human vitamin D receptor.
Sawada D; Tsukuda Y; Saito H; Kakuda S; Takimoto-Kamimura M; Ochiai E; Takenouchi K; Kittaka A
J Am Chem Soc; 2011 May; 133(18):7215-21. PubMed ID: 21500802
[TBL] [Abstract][Full Text] [Related]
9. Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3.
Bouillon R; Sarandeses LA; Allewaert K; Zhao J; Mascareñas JL; Mouriño A; Vrielynck S; de Clercq P; Vandewalle M
J Bone Miner Res; 1993 Aug; 8(8):1009-15. PubMed ID: 8213251
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and properties of 14-epi-1α,25-dihydroxy-19-nortachysterol and its 2-substituted derivatives.
Sawada D; Kittaka A
Curr Top Med Chem; 2014; 14(21):2454-9. PubMed ID: 25486940
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activities of 14-epi-MART-10 and 14-epi-MART-11: implications for cancer and osteoporosis treatment.
Kittaka A; Hara H; Takano M; Sawada D; Arai MA; Takagi K; Chida T; Harada Y; Saito H; Takenouchi K; Ishizuka S; Hayashi K; Ikushiro S; Sakaki T; Sugiura T; Chen TC
Anticancer Res; 2009 Sep; 29(9):3563-9. PubMed ID: 19667149
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of previtamin D(3) analogues with A-ring modifications.
Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M
Bioorg Med Chem; 2008 Dec; 16(24):10244-50. PubMed ID: 19006670
[TBL] [Abstract][Full Text] [Related]
13. Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones.
Saito N; Matsunaga T; Saito H; Anzai M; Takenouchi K; Miura D; Namekawa J; Ishizuka S; Kittaka A
J Med Chem; 2006 Nov; 49(24):7063-75. PubMed ID: 17125259
[TBL] [Abstract][Full Text] [Related]
14. Previtamin D3 with a trans-fused decalin CD-ring has pronounced genomic activity.
Verlinden L; Verstuyf A; Verboven C; Eelen G; De Ranter C; Gao LJ; Chen YJ; Murad I; Choi M; Yamamoto K; Yamada S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R
J Biol Chem; 2003 Sep; 278(37):35476-82. PubMed ID: 12829710
[TBL] [Abstract][Full Text] [Related]
15. 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor.
Molnár F; Sigüeiro R; Sato Y; Araujo C; Schuster I; Antony P; Peluso J; Muller C; Mouriño A; Moras D; Rochel N
PLoS One; 2011 Mar; 6(3):e18124. PubMed ID: 21483824
[TBL] [Abstract][Full Text] [Related]
16. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter CS; Weiskopf AS; Vouros P; Sasso GJ; Uskokovic MR; Wang G; Reddy GS
J Cell Biochem; 2005 Oct; 96(3):569-78. PubMed ID: 16088954
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of vitamin D3 derivatives with nitrogen-linked substituents at A-ring C-2 and evaluation of their vitamin D receptor-mediated transcriptional activity.
Abe J; Nagai Y; Higashikuni R; Iida K; Hirokawa T; Nagai H; Kominato K; Tsuchida T; Hirata M; Inada M; Miyaura C; Nagasawa K
Org Biomol Chem; 2012 Oct; 10(38):7826-39. PubMed ID: 22930071
[TBL] [Abstract][Full Text] [Related]
18. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
[TBL] [Abstract][Full Text] [Related]
19. Human cytochrome P450-dependent differential metabolism among three 2α-substituted-1α,25-dihydroxyvitamin D(3) analogs.
Yasuda K; Ikushiro S; Kamakura M; Takano M; Saito N; Kittaka A; Chen TC; Ohta M; Sakaki T
J Steroid Biochem Mol Biol; 2013 Jan; 133():84-92. PubMed ID: 22982757
[TBL] [Abstract][Full Text] [Related]
20. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
